Literature DB >> 24533274

Monitoring antimalarial drug resistance: Applying lessons learned from the past in a fast-moving present.

Carol Hopkins Sibley1, Ric N Price2.   

Abstract

The need for robust surveillance of antimalarial drugs is more urgent than it has ever been. In the western region of Cambodia, artemisinin resistance has emerged in Plasmodium falciparum and threatens to undermine the efficacy of highly effective artemisinin combination therapies. Although some manfestations of artemisinin tolerance are unique to this class of drug, many of its properties mirror previous experience in understanding and tracking resistance to other antimalarials. In this review we outline the spectrum of approaches that were developed to understand the evolution and spread of antifolate resistance, highlighting the importance of integrating information from different methodologies towards a better understanding of the underlying biologic processes. We consider how to apply our experience in investigating and attempting to contain antifolate resistance to inform our prospective assessment of novel antimalarial resistance patterns and their subsequent spread.

Entities:  

Keywords:  Artemisinin; Drug resistance; Malaria; Surveillance

Year:  2012        PMID: 24533274      PMCID: PMC3862427          DOI: 10.1016/j.ijpddr.2012.03.004

Source DB:  PubMed          Journal:  Int J Parasitol Drugs Drug Resist        ISSN: 2211-3207            Impact factor:   4.077


  91 in total

1.  Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.

Authors:  James G Kublin; Fraction K Dzinjalamala; Deborah D Kamwendo; Elissa M Malkin; Joseph F Cortese; Lisa M Martino; Rabia A G Mukadam; Stephen J Rogerson; Andres G Lescano; Malcolm E Molyneux; Peter A Winstanley; Phillips Chimpeni; Terrie E Taylor; Christopher V Plowe
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

2.  Molecular epidemiology of malaria in Cameroon. XVI. Longitudinal surveillance of in vitro pyrimethamine resistance in Plasmodium falciparum.

Authors:  Leonardo K Basco
Journal:  Am J Trop Med Hyg       Date:  2003-08       Impact factor: 2.345

Review 3.  A network to monitor antimalarial drug resistance: a plan for moving forward.

Authors:  Carol Hopkins Sibley; Karen I Barnes; William M Watkins; Christopher V Plowe
Journal:  Trends Parasitol       Date:  2007-11-26

4.  Resistance to cycloguanil pamoate (CI-501) by falciparum malaria in West Pakistan.

Authors:  P G Contacos; G R Coatney; J S Lunn; W Chin
Journal:  Am J Trop Med Hyg       Date:  1965-11       Impact factor: 2.345

5.  Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children.

Authors:  Fraction K Dzinjalamala; Allan Macheso; James G Kublin; Terrie E Taylor; Karen I Barnes; Malcolm E Molyneux; Christopher V Plowe; Peter J Smith
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

6.  A major genome region underlying artemisinin resistance in malaria.

Authors:  Ian H Cheeseman; Becky A Miller; Shalini Nair; Standwell Nkhoma; Asako Tan; John C Tan; Salma Al Saai; Aung Pyae Phyo; Carit Ler Moo; Khin Maung Lwin; Rose McGready; Elizabeth Ashley; Mallika Imwong; Kasia Stepniewska; Poravuth Yi; Arjen M Dondorp; Mayfong Mayxay; Paul N Newton; Nicholas J White; François Nosten; Michael T Ferdig; Timothy J C Anderson
Journal:  Science       Date:  2012-04-06       Impact factor: 47.728

7.  Observations on monthly pyrimethamine (daraprim) prophylaxis in an East African village.

Authors:  D F CLYDE
Journal:  East Afr Med J       Date:  1954-02

8.  Artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Arjen M Dondorp; François Nosten; Poravuth Yi; Debashish Das; Aung Phae Phyo; Joel Tarning; Khin Maung Lwin; Frederic Ariey; Warunee Hanpithakpong; Sue J Lee; Pascal Ringwald; Kamolrat Silamut; Mallika Imwong; Kesinee Chotivanich; Pharath Lim; Trent Herdman; Sen Sam An; Shunmay Yeung; Pratap Singhasivanon; Nicholas P J Day; Niklas Lindegardh; Duong Socheat; Nicholas J White
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

9.  Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006.

Authors:  Laura K Certain; Marnie Briceño; Steven M Kiara; Alexis M Nzila; William M Watkins; Carol Hopkins Sibley
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 5.226

10.  Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.

Authors:  Alisa P Alker; Pharath Lim; Rithy Sem; Naman K Shah; Poravuth Yi; Denis Mey Bouth; Reiko Tsuyuoka; Jason D Maguire; Thierry Fandeur; Frederic Ariey; Chansuda Wongsrichanalai; Steven R Meshnick
Journal:  Am J Trop Med Hyg       Date:  2007-04       Impact factor: 2.345

View more
  10 in total

1.  Ahead of the curve: next generation estimators of drug resistance in malaria infections.

Authors:  Nicole Mideo; David A Kennedy; Jane M Carlton; Jeffrey A Bailey; Jonathan J Juliano; Andrew F Read
Journal:  Trends Parasitol       Date:  2013-06-05

2.  Host-based Prophylaxis Successfully Targets Liver Stage Malaria Parasites.

Authors:  Alyse N Douglass; Heather S Kain; Marian Abdullahi; Nadia Arang; Laura S Austin; Sebastian A Mikolajczak; Zachary P Billman; Jen C C Hume; Sean C Murphy; Stefan H I Kappe; Alexis Kaushansky
Journal:  Mol Ther       Date:  2015-02-04       Impact factor: 11.454

Review 3.  Antimicrobial activity of oleanolic and ursolic acids: an update.

Authors:  Jéssica A Jesus; João Henrique G Lago; Márcia D Laurenti; Eduardo S Yamamoto; Luiz Felipe D Passero
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-22       Impact factor: 2.629

4.  Analysis of major genome loci underlying artemisinin resistance and pfmdr1 copy number in pre- and post-ACTs in western Kenya.

Authors:  Bidii S Ngalah; Luiser A Ingasia; Agnes C Cheruiyot; Lorna J Chebon; Dennis W Juma; Peninah Muiruri; Irene Onyango; Jack Ogony; Redemptah A Yeda; Jelagat Cheruiyot; Emmanuel Mbuba; Grace Mwangoka; Angela O Achieng; Zipporah Ng'ang'a; Ben Andagalu; Hoseah M Akala; Edwin Kamau
Journal:  Sci Rep       Date:  2015-02-06       Impact factor: 4.379

5.  Observing in real time the evolution of artemisinin resistance in Plasmodium falciparum.

Authors:  Carol Hopkins Sibley
Journal:  BMC Med       Date:  2015-03-31       Impact factor: 8.775

Review 6.  Evaluating drug resistance in visceral leishmaniasis: the challenges.

Authors:  S Hendrickx; P J Guerin; G Caljon; S L Croft; L Maes
Journal:  Parasitology       Date:  2016-11-21       Impact factor: 3.234

Review 7.  Evaluation of residual submicroscopic Plasmodium falciparum parasites 3 days after initiation of treatment with artemisinin-based combination therapy.

Authors:  Richard Mwaiswelo; Bill Ngasala
Journal:  Malar J       Date:  2020-04-21       Impact factor: 2.979

8.  Interactions of primaquine and chloroquine with PEGylated phosphatidylcholine liposomes.

Authors:  Andang Miatmoko; Ira Nurjannah; Nuril Fadilatul Nehru; Noorma Rosita; Esti Hendradi; Retno Sari; Juni Ekowati
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

Review 9.  The influence of host genetics on erythrocytes and malaria infection: is there therapeutic potential?

Authors:  Patrick M Lelliott; Brendan J McMorran; Simon J Foote; Gaetan Burgio
Journal:  Malar J       Date:  2015-07-29       Impact factor: 2.979

Review 10.  Bibliometric Analysis of Worldwide Publications on Antimalarial Drug Resistance (2006-2015).

Authors:  Waleed M Sweileh; Samah W Al-Jabi; Ansam F Sawalha; Adham S AbuTaha; Sa'ed H Zyoud
Journal:  Malar Res Treat       Date:  2017-08-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.